In 2020, the path forward for psychedelic drug research goes in several directions.
Scientists Synthesize and Test the Magic Mushroom Compounds Baeocystin, Norbaeocystin, Norpsilocin, and Aeruginascin
This work is a giant step forward for psychedelic research.
The Miller School of Medicine is Studying CBD + Psilocybin for Treating Traumatic Brain Injury and PTSD
The University of Miami medical school study is funded by a $1.624 million grant from Tassili Life Sciences.
Recent research suggests that psilocybin causes changes in amygdala activity opposite to those seen in conventional antidepressant treatment.
Even slightly modifying the chemical structure of the compounds in kratom can significantly alter their effects.
After 4.5 years, 60-80% of the study participants with life-threatening cancer still experienced significantly decreased anxiety or antidepressant effects.
A research team including psychedelics expert Dr. Roland Griffiths recently published a study examining how context (the set and setting) impacts the effects of inhaling 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine).1 Previous research strongly...
The authors argue that the serotonergic mediation of estrogen has important clinical implications and warrants further investigation.
2000 Study Finds Estrogen + Progesterone Increases Cortical 5-HT2A Receptor Binding Potential in Postmenopausal Women
The hormone combination increased 5-HT2A binding potential over 20%.
The increase was seen primarily in the cerebral cortex and the nucleus accumbens.